Abstract

BackgroundCystatin C (CysC), is produced by all the nucleated cells of the human body, is freely filtered by the kidney glomerulus and reabsorbed by the tubules. It is widely accepted that no tubular secretion of CysC occurs. Raised urinary levels are believed to indicate tubular damage. MethodsWe report here the validation of a quantitative assay to measure urinary cystatin C (uCysC) using a commercial CysC kit based on a latex particle-enhanced turbidimetric immunoassay (PETIA), on an automated biochemistry analyzer. The clinical relevance of this assay was tested on several kidney disease patients and a reference range was determined using healthy controls. ResultsThe assay is precise (total CV<4%), and sensitive (limit of quantification=0.06mg/dL, and limit of detection=0.02mg/L). Calibration is stable for at least 30days. The assay showed very good linearity over the studied interval (0.02 to 2.25mg/L). Recovery ranged from 101.62 to 106.49%. The analyte is stable, at 4°C for at least 2days, and at 20°C for 48h. The upper reference value was 0.12mg/L Median uCysC concentration in 30 acute kidney injury patients (1.47mg/L, interquartile range=0.27–3.87mg/L) and was significantly higher than that in 25 patients with normal kidney function (0.05, 0.03–0.12; p<0.0001), 30 patients with chronic kidney disease (0.13, 0.05–0.77; p<0.0001) and 15 patients with pre-renal azotemia (0.15, 0.08–0.31; p<0.0001). ConclusionOur data indicate that uCysC can be processed on automated biochemistry analyzers and its measurement could easily be added to a standard panel to screen kidney diseases.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.